Alopecia - Pipeline Review, H2 2017 - Product Image

Alopecia - Pipeline Review, H2 2017

  • ID: 4330509
  • Report
  • Region: Global
  • 143 Pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • Aclaris Therapeutics Inc
  • AndroScience Corp
  • BirchBioMed Inc
  • Handok Inc
  • LEO Pharma A/S
  • Panacea Biotec Ltd
  • MORE
Alopecia - Pipeline Review, H2 2017

Summary:

The latest Pharmaceutical and Healthcare disease pipeline guide Alopecia - Pipeline Review, H2 2017, provides an overview of the Alopecia (Dermatology) pipeline landscape.

Alopecia is the partial or complete loss of hair especially on the scalp either in patches, on the entire head or over the entire body. Thinning hair is the most obvious symptom. The predisposing factors include allergies, irritants, toxins, burns, injuries, and infections.

Report Highlights:

The latest Pharmaceutical and Healthcare latest pipeline guide Alopecia - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Alopecia (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Alopecia (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 1, 12, 5, 1, 19 and 9 respectively. Similarly, the Universities portfolio in Phase III and Discovery stages comprises 1 and 1 molecules, respectively.

Alopecia (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from our proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Alopecia (Dermatology).
  • The pipeline guide reviews pipeline therapeutics for Alopecia (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Alopecia (Dermatology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Alopecia (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Alopecia (Dermatology)
Reasons to Buy:
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Alopecia (Dermatology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Alopecia (Dermatology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Aclaris Therapeutics Inc
  • AndroScience Corp
  • BirchBioMed Inc
  • Handok Inc
  • LEO Pharma A/S
  • Panacea Biotec Ltd
  • MORE
Introduction

Alopecia - Overview

Alopecia - Therapeutics Development

Pipeline Overview

Pipeline by Companies

Pipeline by Universities/Institutes

Products under Development by Companies

Products under Development by Universities/Institutes

Alopecia - Therapeutics Assessment

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Alopecia - Companies Involved in Therapeutics Development

Aclaris Therapeutics Inc

Allergan Plc

Almirall SA

AndroScience Corp

Berg LLC

BiologicsMD Inc

BirchBioMed Inc

Brickell Biotech Inc

Bristol-Myers Squibb Company

Cassiopea SpA

Daewoong Pharmaceutical Co Ltd

Dong-A Socio Holdings Co Ltd

Handok Inc

Histogen Inc

Hyundai Pharmaceutical Co Ltd

Incyte Corp

Kuhnil Pharmaceutical Co Ltd

Lee's Pharmaceutical Holdings Ltd

LEO Pharma A/S

Medivir AB

NovaLead Pharma Pvt Ltd

Panacea Biotec Ltd

Pfizer Inc

Quark Pharmaceuticals Inc

RXi Pharmaceuticals Corp

Samumed LLC

Switch Biotech LLC

Taisho Pharmaceutical Holdings Co Ltd

Tigo GmbH

viDA Therapeutics Inc

Alopecia - Drug Profiles

(cyclosporine A + minoxidil + RT-175) - Drug Profile

abatacept - Drug Profile

AI-001 - Drug Profile

Antibodies to Inhibit Heparanase for Alopecia, Colitis, Diabetic Nephropathy, Transplantation and Oncology - Drug Profile

Antisense Oligonucleotide to Inhibit Androgen Receptor for Alopecia - Drug Profile

ASCJ-9 - Drug Profile

ATI-50001 - Drug Profile

ATI-50002 - Drug Profile

ATI-50003 - Drug Profile

BBI-5000 - Drug Profile

BMD-1141 - Drug Profile

BMD-1341 - Drug Profile

BMD-2341 - Drug Profile

BQ-A - Drug Profile

BRM-421 - Drug Profile

calcitriol - Drug Profile

CB-0301 - Drug Profile

DHL-HisZnNa - Drug Profile

finasteride - Drug Profile

finasteride - Drug Profile

FOL-005 - Drug Profile

HGEN-001 - Drug Profile

HL-5945 - Drug Profile

HTB-005 - Drug Profile

interferon beta-1b - Drug Profile

KI-1104 - Drug Profile

KI-1105 - Drug Profile

LEO-124249 - Drug Profile

minoxidil - Drug Profile

NLP-602 - Drug Profile

OLX-104 - Drug Profile

PF-06651600 - Drug Profile

PF-06700841 - Drug Profile

QPAL-1 - Drug Profile

QPAL-2 - Drug Profile

RBAG-010 - Drug Profile

Recombinant Proteins to Agonize EGFR for Alopecia and Arthritis - Drug Profile

Recombinant Proteins to Antagonize IFN-Gamma Receptor 1 for Alopecia Areata and Graft Arteriosclerosis - Drug Profile

remetinostat - Drug Profile

ruxolitinib phosphate - Drug Profile

Samcyprone - Drug Profile

setipiprant - Drug Profile

SM-04554 - Drug Profile

Small Molecule for Androgenic Alopecia - Drug Profile

Small Molecules to Inhibit JAK for Alopecia Areata, Androgenetic Alopecia and Dermatological Disorders - Drug Profile

Synthetic Peptide for Alopecia - Drug Profile

TP-0427736 - Drug Profile

TS-133 - Drug Profile

VTI-1000 Series - Drug Profile

ZK-003 - Drug Profile

Alopecia - Dormant Projects

Alopecia - Discontinued Products

Alopecia - Product Development Milestones

Featured News & Press Releases

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables:

Number of Products under Development for Alopecia, H2

Number of Products under Development by Companies, H2

Number of Products under Development by Companies, H2 2017 (Contd..1), H2

Number of Products under Development by Universities/Institutes, H2

Products under Development by Companies, H2

Products under Development by Companies, H2 2017 (Contd..1), H2

Products under Development by Companies, H2 2017 (Contd..2), H2

Products under Development by Universities/Institutes, H2

Number of Products by Stage and Target, H2

Number of Products by Stage and Target, H2 2017 (Contd..1), H2

Number of Products by Stage and Mechanism of Action, H2

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..1), H2

Number of Products by Stage and Route of Administration, H2

Number of Products by Stage and Molecule Type, H2

Alopecia - Pipeline by Aclaris Therapeutics Inc, H2

Alopecia - Pipeline by Allergan Plc, H2

Alopecia - Pipeline by Almirall SA, H2

Alopecia - Pipeline by AndroScience Corp, H2

Alopecia - Pipeline by Berg LLC, H2

Alopecia - Pipeline by BiologicsMD Inc, H2

Alopecia - Pipeline by BirchBioMed Inc, H2

Alopecia - Pipeline by Brickell Biotech Inc, H2

Alopecia - Pipeline by Bristol-Myers Squibb Company, H2

Alopecia - Pipeline by Cassiopea SpA, H2

Alopecia - Pipeline by Daewoong Pharmaceutical Co Ltd, H2

Alopecia - Pipeline by Dong-A Socio Holdings Co Ltd, H2

Alopecia - Pipeline by Handok Inc, H2

Alopecia - Pipeline by Histogen Inc, H2

Alopecia - Pipeline by Hyundai Pharmaceutical Co Ltd, H2

Alopecia - Pipeline by Incyte Corp, H2

Alopecia - Pipeline by Kuhnil Pharmaceutical Co Ltd, H2

Alopecia - Pipeline by Lee's Pharmaceutical Holdings Ltd, H2

Alopecia - Pipeline by LEO Pharma A/S, H2

Alopecia - Pipeline by Medivir AB, H2

Alopecia - Pipeline by NovaLead Pharma Pvt Ltd, H2

Alopecia - Pipeline by Panacea Biotec Ltd, H2

Alopecia - Pipeline by Pfizer Inc, H2

Alopecia - Pipeline by Quark Pharmaceuticals Inc, H2

Alopecia - Pipeline by RXi Pharmaceuticals Corp, H2

Alopecia - Pipeline by Samumed LLC, H2

Alopecia - Pipeline by Switch Biotech LLC, H2

Alopecia - Pipeline by Taisho Pharmaceutical Holdings Co Ltd, H2

Alopecia - Pipeline by Tigo GmbH, H2

Alopecia - Pipeline by viDA Therapeutics Inc, H2

Alopecia - Dormant Projects, H2

Alopecia - Dormant Projects, H2 2017 (Contd..1), H2

Alopecia - Discontinued Products, H2

List of Figures:

Number of Products under Development for Alopecia, H2

Number of Products under Development by Companies, H2

Number of Products under Development by Universities/Institutes, H2

Number of Products by Top 10 Targets, H2

Number of Products by Stage and Top 10 Targets, H2

Number of Products by Top 10 Mechanism of Actions, H2

Number of Products by Stage and Top 10 Mechanism of Actions, H2

Number of Products by Routes of Administration, H2

Number of Products by Stage and Routes of Administration, H2

Number of Products by Top 10 Molecule Types, H2

Number of Products by Stage and Top 10 Molecule Types, H
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Aclaris Therapeutics Inc
  • Allergan Plc
  • Almirall SA
  • AndroScience Corp
  • Berg LLC
  • BiologicsMD Inc
  • BirchBioMed Inc
  • Brickell Biotech Inc
  • Bristol-Myers Squibb Company
  • Cassiopea SpA
  • Daewoong Pharmaceutical Co Ltd
  • Dong-A Socio Holdings Co Ltd
  • Handok Inc
  • Histogen Inc
  • Hyundai Pharmaceutical Co Ltd
  • Incyte Corp
  • Kuhnil Pharmaceutical Co Ltd
  • Lee's Pharmaceutical Holdings Ltd
  • LEO Pharma A/S
  • Medivir AB
  • NovaLead Pharma Pvt Ltd
  • Panacea Biotec Ltd
  • Pfizer Inc
  • Quark Pharmaceuticals Inc
  • RXi Pharmaceuticals Corp
  • Samumed LLC
  • Switch Biotech LLC
  • Taisho Pharmaceutical Holdings Co Ltd
  • Tigo GmbH
  • viDA Therapeutics Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll